Understanding Miller-Dieker Syndrome: An Introduction
At a Glance
Miller-Dieker Syndrome (MDS) is a rare genetic condition caused by a missing section of chromosome 17. This genetic deletion prevents normal brain cell movement during fetal development, resulting in a smooth brain (lissencephaly), seizures, and severe developmental delays.
Receiving a diagnosis of Miller-Dieker Syndrome (MDS) can feel overwhelming and deeply isolating. It is natural to feel a range of emotions—grief, confusion, or even a sense of injustice—as you begin to navigate this complex diagnosis. Understanding the biological “why” behind MDS is not a fix for the emotional weight you carry, but it can provide a foundation of knowledge as you advocate for your child’s care.
What is Miller-Dieker Syndrome?
Miller-Dieker Syndrome (MDS) is a rare genetic condition that primarily affects the development of the brain [1]. It is characterized by a specific pattern of brain malformation known as lissencephaly [2]. While every child is unique, MDS often involves severe developmental delays, intellectual disabilities, and seizures that typically begin in infancy [1].
The Genetic “Blueprint”: 17p13.3 Microdeletion
The human body is built from instructions found in our chromosomes. In most cases of MDS, a small piece of genetic material is missing from the “short arm” (the p arm) of chromosome 17 [3].
This is called a 17p13.3 microdeletion. Because this specific area contains several important genes located right next to each other, MDS is known as a contiguous gene deletion syndrome [3]. In roughly 90% of cases, this deletion is a random event (called a de novo mutation) that happens during the formation of the egg or sperm, or very early in fetal development.
Understanding Lissencephaly
The hallmark of MDS is lissencephaly, a term derived from Greek meaning “smooth brain” [4].
- Normal Brain Development: In a typically developing brain, the outer layer (the cerebral cortex—the part of the brain responsible for movement and thought) folds into complex grooves and ridges. These folds allow a large amount of brain tissue to fit inside the skull.
- What Happens in MDS: During fetal development, young brain cells (neurons) must travel from the center of the brain to the outer edges to form these folds. This process is called neuronal migration [4]. In MDS, this journey is interrupted. The neurons “stall” before they reach their destination, resulting in a brain surface that is smooth rather than folded [5][6].
The Role of Missing Genes
While several genes may be missing in the 17p13.3 region, three specific genes are often highlighted because of their critical roles in brain and body development:
| Gene | Role in Development | Impact of Deletion |
|---|---|---|
| PAFAH1B1 (also called LIS1) | Acts like a “motor” or “guide” for neurons, helping them move to the correct layers of the brain [5]. | Loss of this gene is the primary cause of lissencephaly in MDS [7]. |
| YWHAE | Helps stabilize the structures that neurons use to move [8]. | When this gene is missing along with PAFAH1B1, the lissencephaly is often more severe [9]. |
| CRK | Involved in signaling pathways that tell the body how to grow [10]. | Missing this gene is often linked to the slower growth and smaller stature seen in many children with MDS [10][11]. |
The Diagnostic Path
Doctors use specialized tools to confirm a diagnosis of Miller-Dieker Syndrome:
- Neuroimaging: An MRI (Magnetic Resonance Imaging) is used to look at the structure of the brain and confirm the presence of lissencephaly [1].
- Genetic Testing: A Chromosomal Microarray (CMA) is the standard test used to identify exactly which parts of chromosome 17 are missing [12][13]. This helps distinguish MDS from other forms of lissencephaly that might be caused by single-gene mutations rather than a larger deletion [3].
Understanding these genetic foundations is the first step in preparing for the journey ahead. Your care team will use this information to create a supportive plan tailored to your child’s specific needs.
Common questions in this guide
What causes Miller-Dieker Syndrome?
What does lissencephaly mean for my child's brain?
How is Miller-Dieker Syndrome diagnosed?
Is Miller-Dieker Syndrome inherited from parents?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Which specific genes are included in my child's 17p13.3 deletion?
- 2.Does the deletion size or the specific genes missing help us understand what symptoms or challenges to expect?
- 3.Is the lissencephaly considered 'classic' or 'grade 1,' and how does that affect the long-term outlook?
- 4.Was this deletion a 'de novo' event, or should we be tested for a balanced translocation?
- 5.What multidisciplinary specialists (like neurologists or geneticists) should be on our care team?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (13)
- 1
Diagnosis of Lissencephaly in a Neonate After Antenatal Polyhydramnios and Suspicion of Fetal Esophageal Atresia: A Case Report.
Watanabe H, Ibi K, Yoneda K, Kakiuchi S
Cureus 2025; (17(9)):e92565 doi:10.7759/cureus.92565.
PMID: 41111707 - 2
In vitro modeling for inherited neurological diseases using induced pluripotent stem cells: from 2D to organoid.
Nam KH, Yi SA, Jang HJ, et al.
Archives of pharmacal research 2020; (43(9)):877-889 doi:10.1007/s12272-020-01260-z.
PMID: 32761309 - 3
Further expansion and confirmation of phenotype in rare loss of YWHAE gene distinct from Miller-Dieker syndrome.
Baker EK, Brewer CJ, Ferreira L, et al.
American journal of medical genetics. Part A 2023; (191(2)):526-539 doi:10.1002/ajmg.a.63057.
PMID: 36433683 - 4
Comprehensive genotype-phenotype correlation in lissencephaly.
Tan AP, Chong WK, Mankad K
Quantitative imaging in medicine and surgery 2018; (8(7)):673-693 doi:10.21037/qims.2018.08.08.
PMID: 30211035 - 5
Impairment in dynein-mediated nuclear translocation by BICD2 C-terminal truncation leads to neuronal migration defect and human brain malformation.
Tsai MH, Cheng HY, Nian FS, et al.
Acta neuropathologica communications 2020; (8(1)):106 doi:10.1186/s40478-020-00971-0.
PMID: 32665036 - 6
Multiplex Consanguineous Family Highlights CLASP1 as a Candidate Gene for Lissencephaly.
Alsafh R, Alhashem A, Elsyed A, et al.
Neurology. Genetics 2024; (10(4)):e200172 doi:10.1212/NXG.0000000000200172.
PMID: 39040917 - 7
Heterozygous inversion on chromosome 17 involving PAFAH1B1 detected by whole genome sequencing in a patient suffering from pachygyria.
Chen J, Li XP, Luo GJ, et al.
European journal of medical genetics 2025; (73()):104991 doi:10.1016/j.ejmg.2024.104991.
PMID: 39709006 - 8
Neuronal migration genes and a familial translocation t (3;17): candidate genes implicated in the phenotype.
Hadj Amor M, Dimassi S, Taj A, et al.
BMC medical genetics 2020; (21(1)):26 doi:10.1186/s12881-020-0966-9.
PMID: 32028920 - 9
17p13.3 microdeletion including YWHAE and CRK genes: towards a clinical characterization.
Romano C, Ferranti S, Mencarelli MA, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2020; (41(8)):2259-2262 doi:10.1007/s10072-020-04424-3.
PMID: 32323081 - 10
Crk Haploinsufficiency Is Associated with Intrauterine Growth Retardation and Severe Postnatal Growth Failure.
Deodati A, Inzaghi E, Germani D, et al.
Hormone research in paediatrics 2021; (94(11-12)):456-466 doi:10.1159/000521629.
PMID: 35086092 - 11
Disruption of YWHAE gene at 17p13.3 causes learning disabilities and brain abnormalities.
Noor A, Bogatan S, Watkins N, et al.
Clinical genetics 2018; (93(2)):365-367 doi:10.1111/cge.13056.
PMID: 28542865 - 12
Identify latent chromosomal aberrations relevant to myelodysplastic syndromes.
Song Q, Chu Y, Yao Y, et al.
Scientific reports 2017; (7(1)):10354 doi:10.1038/s41598-017-10551-3.
PMID: 28871208 - 13
Prenatal diagnosis of Miller-Dieker syndrome/PAFAH1B1-related lissencephaly: Ultrasonography and genetically investigative results.
Zhang YL, Jing XY, Zhen L, et al.
European journal of obstetrics, gynecology, and reproductive biology 2022; (274()):28-32 doi:10.1016/j.ejogrb.2022.04.025.
PMID: 35567955
This page provides an introduction to Miller-Dieker Syndrome for educational purposes. Always consult your pediatric neurologist and geneticist regarding your child's specific diagnosis, genetic testing, and care plan.
Get notified when new evidence is published on Miller-Dieker syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.